Clinical Trial Update: To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update announces an early Phase 1 study to evaluate the safety and potential efficacy of GS1168 Injection in adults with phenylketonuria; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• GS1168 (GS1168)

Snippet

Sponsor: Gritgen Therapeutics Co., Ltd. | Conditions: Phenylketonuria (PKU) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING